Marie Robert
Rene, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Phase I safety, efficacy, and biomarker response evaluations of three oral PD-L1 inhibitors: INCB086550, INCB099280, and INCB099318.
Journal: Journal for immunotherapy of cancer
Published: July 27, 2026
Not just splitting hairs-monitoring environmental chemical exposures, their biological effects and their social determinants with hair shafts and follicles: a narrative review.
Journal: Environmental health : a global access science source
Published: January 30, 2026
A Phase 1 dose-escalation study to evaluate safety, pharmacokinetics, and pharmacodynamics of OSE-279, an anti-PD-1 monoclonal antibody in patients with advanced solid tumours.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 02, 2026
Favourable long-term outcomes in selected HER2-Positive early breast cancer patients without pathological complete response after neoadjuvant chemotherapy and trastuzumab: A pre-T-DM1 era cohort study.
Journal: Cancer treatment and research communications
Published: August 04, 2025
Prospective pilot study with [89Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE).
Journal: European journal of nuclear medicine and molecular imaging
Published: July 10, 2025
Real-world analysis of HER2-ultralow in HR+/HER2- metastatic breast cancer: prevalence and first-line chemotherapy outcomes.
Journal: Therapeutic advances in medical oncology
Published: May 02, 2025
Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations.
Journal: JCO clinical cancer informatics
Published: March 20, 2025
Edible squash poisoning: cause of hair loss and exanthema.
Journal: Annales de dermatologie et de venereologie
Published: December 15, 2024
Adherence to endocrine therapy: A major issue in breast cancer management
Journal: Bulletin du cancer
Published: February 07, 2024
A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules.
Journal: Pharmaceutics
Published: September 18, 2023
Evaluating everolimus for the treatment of breast cancer.
Journal: Expert opinion on pharmacotherapy
Published: May 15, 2023
Last Updated: 09/26/2026